Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Launches MassArray Assay Design and Validation Services

NEW YORK, Sept. 22 (GenomeWeb News) - Sequenom is offering a new assay development and validation service for its MassArray platform, the company said today.

 

Customers of the company's MassArray system can submit data for a customized assay through a website and are promised to obtain a validated assay within 12 business days.

 

Sequenom hopes the new service will create a new consumables revenue stream and long-term customer relationships.

 

For more in-depth information, see an article in this week's Pharmacogenomics Reporter.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more